SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-020624
Filing Date
2015-11-12
Accepted
2015-11-12 16:07:15
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vbiv20150930_10q.htm 10-Q 588090
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14206
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14399
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6091
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6132
  Complete submission text file 0001437749-15-020624.txt   3088541

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS vbiv-20150930.xml EX-101.INS 441002
7 EXHIBIT 101.SCH vbiv-20150930.xsd EX-101.SCH 33770
8 EXHIBIT 101.CAL vbiv-20150930_cal.xml EX-101.CAL 30779
9 EXHIBIT 101.DEF vbiv-20150930_def.xml EX-101.DEF 263771
10 EXHIBIT 101.LAB vbiv-20150930_lab.xml EX-101.LAB 217637
11 EXHIBIT 101.PRE vbiv-20150930_pre.xml EX-101.PRE 274963
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 6178303031
VBI VACCINES INC. (Filer) CIK: 0000704159 (see all company filings)

IRS No.: 930589534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-18188 | Film No.: 151224847
SIC: 2836 Biological Products, (No Diagnostic Substances)